Pharmacy Podcast Network - TopPodcast.com

View Top 200 Chart

Back to Rankings Page

Pharmacy Podcast Network — Business
Pharmacy Podcast Network

Pharmacy Podcast Network (PPN) is the world’s largest network of podcasts dedicated to the pharmacy professional and industry insiders. Our content is about dynamic people in the pharmacy industry making a difference and delivering the best pharmacy care. We have over 40+ podcasts with thousands of interviews.

Pharmacists are the cornerstone of healthcare, and the PPN reflects that. From Community, LTC, Specialty Pharmacy to Drug Development, Government policy and DigitalHealth, we cover it all. Partner with us to connect with thousands of daily listeners and find the right pharmacist across various specialties and topics, ensuring your products and services resonate where it matters most. We build strong audio brands through Pharmacists who see patients almost 9x more than primary care.

Join the home of the O.G. Pharmacy Podcast & discover our newest development: Evidence-based Podcasting, the first CME supplement in podcast form that’s truly peer-reviewed. The future of podcasting education for Providers is “Evidence-based Podcasting” (TM) and we’re building a peer-review board, reach out to us: Publisher @ Pharmacy Podcast dot com.

PPN is a division of RxPR, LLC. Copyright 2026

Latest Episodes:

Dr. Greg Dewey on Retirement, Accomplishments, and Social Entrepreneurship Jul 11, 2022

Show notes

During his eight-year tenure at Albany College of Pharmacy and Health Sciences, Dr. Greg Dewey accomplished many great things. In this episode of Occupation Station Dr. Dewey reflects on The Collaboratory, the Stack Family Center for Biopharmaceutical Education and Training (CBET), and the creation of two student-run pharmacies. The Collaboratory, a “laboratory for collaboration,” offers services which are delivered to residents in Albany by ACPHS’s Public Health Pharmacy Team and Trinity Alliance’s Wellness Advocates Linking Communities (WALC) team. Programs at The Collaboratory address social justice and social determinants of health with the shared goal of improving population health. CBET is an evolutionary leap in health sciences education and biomanufacturing workforce training. Dr. Dewey is perhaps most proud of the creation of two student-run pharmacies both situated in what would be deemed “pharmacy deserts.” The pharmacies, which are located in Albany and Schenectady, N.Y., are prime examples of social entrepreneurship and are designed to have a lasting impact on the communities they serve, while also helping to develop skills that students will benefit from. Dr. Dewey explains that social entrepreneurship involves being self-sustaining while doing public good. Because of his relationships with faculty, staff, and students, coupled with the development of these crucial initiatives, Dr. Dewey has found his work at ACPHS to be greatly gratifying. And because of his enormous contributions at ACPHS he will be greatly missed! Learn more about your ad choices. Visit megaphone.fm/adchoices

Pharmacists Impact on Biosimilar Adoption with special guest Sonia Oskouei, PharmD Jul 09, 2022

Show notes

As an innovative method to improve the affordability of costly biological therapies, there's new medication products being developed with the needed approval of the Food and Drug Administration (FDA) for biological products that are “highly similar” (biosimilar) to or interchangeable with traditional drug developed products. Biosimilars are not completely identical to the innovator product because of the large molecular size, complexity and proprietary nature of the manufacturing process, and inherent variability of all biopharmaceuticals. Dr. Sonia Oskouei, PharmD, BCMAS, DPLA is Vice President of Biosimilars at Cardinal Health. Sonia shares her experiences in the biosimilars sector of drug development and shares how we're entering these new therapeutic areas, with ophthalmology being the latest focus. Sonia explains how we need more information to help build clinical confidence in these agents. So, any type of data or evidence in understanding of the FDA approval pathway and the associated scientific rigor from the FDA is key to helping build clinical confidence. "Pharmacists are becoming more and more involved in the care team, particularly in oncology and in the health system setting. So, pharmacists often are partnering or leading with physicians to champion the education process associated with biosimilars, and that's multistakeholder education, both physicians, other pure pharmacists, and supporting patients and their journey. Pharmacists are also strong contributors to biosimilar adoption and management, particularly in the health system setting as a lead often for formulary decisions, P&T committee involvement, where they're looking not only at the clinical considerations of biosimilars but incorporating the economic and even operational considerations associated with these products, so understanding the complete picture and how best to optimize and leverage biosimilars within their institutions." Learn more about your ad choices. Visit megaphone.fm/adchoices

Postpartum Sexual Health | Sex PharmD Jul 08, 2022

Show notes

Daisy Bravo is an online pregnancy & postpartum fitness coach and the founder of Strong Moms Fitness. Her passion for health and fitness has led her to a 20-year career supporting moms to reach their health and fitness goals. Early on in her personal training career, she noticed that many trainers in the gym did not know what to do with pregnant women and new mothers. She identified two types of trainers; the ones that we’re afraid to work with moms and the ones that either ignored or were unaware that these women needed special consideration. Sick of seeing this population ignored in standard fitness programs, and also wanting for herself to have a fit pregnancy. Daisy spent years learning how to help herself and other women have an empowered pregnancy. It wasn’t long into her studies that Daisy realized it was her destiny to work with pregnant and postpartum women and continue to raise awareness that women can be a badass in the gym…even if they are pregnant or a new mom. Daisy’s mission is to support moms who feel pressure from society to quickly lose weight after baby. In their effort to look good on the outside it is so common to see moms resume pre-baby activities only to find themselves injured and left to accept that things like diastasis, prolapse, and leakage are normal. Through Daisy’s coaching programs she supports, empowers, and educates women on how to workout safely during pregnancy and then recover and return to exercise after giving birth, without risking injury and avoiding those crash diets. Social Media - WEBSITE | INSTAGRAM | FACEBOOK GROUP | PINTEREST | YOUTUBE Podcast - https://www.strongmomsfitnesspodcast.com/ Book - http://flatabsafterbaby.com/ use coupon code PHARMACIST for 20% off Media Kit with Bio & Images - Daisy Bravo Media Kit - Strong Moms Fitness Learn more about your ad choices. Visit megaphone.fm/adchoices

Uncovering The First Year of Medical School with Dr. Tim Do | The Physician Pharmacist Podcast Jul 07, 2022

Show notes

Have you ever considered a career in medicine after pharmacy? Join us today to explore what the first year of medical school is like and how it compares to pharmacy! In today’s show, we will cover topics related to application logistics, basic MCAT principles, application timing, applying to pharmacy residencies, tackling pharmacy boards, adjusting to the medical school life, and reflections on a career in medicine! Links: 1. Medical School Application Platform; AMCAS - https://students-residents.aamc.org/ 2. American Association of Colleges of Osteopathic Medicine (AACOM): - https://www.aacom.org/ 3. Medical School Acceptance Rates By Major in 2022 (BeMo) - https://bemoacademicconsulting.com/blog/medical-school-acceptance-rates-by-major Learn more about your ad choices. Visit megaphone.fm/adchoices

Congressman Buddy Carter and General Counsel of NCPA Matthew Seiler on PBM Reform Jul 06, 2022

Show notes

Congressman Buddy Carter and General Counsel of NCPA Matthew Seiler on PBM Reform. On this episode of the 'PBM Reform Podcast' we discuss the Pharmacy Benefit Manager (PBM) Transparency Act of 2022 (the Act) was recently proposed in the U.S. Senate and intends to incentivize “fair and transparent” PBM practices, prohibit spread pricing and claw backs of payments to pharmacies, and empower the Federal Trade Commission (FTC) and state attorneys general in enforcement actions to stop “unfair and deceptive” PBM business practices. The Act was introduced by Senators Maria Cantwell Chuck Grassley on May 24, 2022, and was approved by the Commerce Committee with bipartisan support (19-9) on June 22, 2022. This summary provides a high-level overview of the Act’s key measures. Prohibition on Unfair or Deceptive Prescription Drug Pricing Practices The Act would make it illegal for PBMs to: Engage in “spread pricing,” which is described as charging a health plan or payer a different amount for a prescription drug’s ingredient cost or dispensing fee than the amount the PBM reimburses a pharmacy for the prescription drug’s ingredient cost or dispensing fee where the PBM retains the amount of any such difference; Arbitrarily, unfairly, or deceptively reduce or rescind (a.k.a. “claw back”) any portion of the reimbursement payment to a pharmacist or pharmacy for a prescription drug’s ingredient cost of dispensing fee; or Arbitrarily, unfairly, or deceptively increase or lower fees and reimbursements to a pharmacy to offset reimbursement changes under any federally funded health plan. The Act would incentivize transparency by stating that a PBM shall not be in violation of the Act if the PBM passes through 100% of price concessions to a health plan or payer and provides complete disclosure of: The cost, price, and reimbursement of prescription drugs to each health plan, payer, and pharmacy; All fees, markups, and discounts the PBM charges or imposes on each health plan, payer, and pharmacy; and The aggregate remuneration PBM receives from drug manufacturers, including nay rebate, discount, administration fee, and any other payment or credit obtained or retained by PBM. Learn more about your ad choices. Visit megaphone.fm/adchoices

Pharmacists Leading in Public Health | Pharmacy Podcast Nation Jul 04, 2022

Show notes

Dr. Jennifer N. Lind, PharmD, MPH, MBA Jennifer N. Lind, PharmD, MPH, MBA, is a Pharmacist and Epidemiologist in CDC’s Medication Safety Program and a Commander in the United States Public Health Service Commissioned Corps. CDR Lind received her Doctor of Pharmacy degree from Florida A&M University in 2007, Master of Public Health from Georgia State University in 2012, and Master of Business Administration from Emory University in May 2022. After receiving her MPH, she completed a two-year fellowship as an Epidemic Intelligence Service (EIS) officer in CDC’s National Center for Chronic Disease Prevention and Health Promotion, conducting research and surveillance related to infant and young child feeding practices. Following EIS, she worked in CDC’s Birth Defects Branch and eventually became the Lead Scientist for CDC’s Treating for Two initiative, focused on safer medication use in pregnancy. CDR Lind’s current work in CDC’s Medication Safety Program focuses on reducing harms from the use of medications and she serves as Lead Pharmacist for the PROTECT initiative, an innovative public-private partnership that uses a collaborative, data-driven approach to reduce harms from unintentional medication overdoses in children. CDR Lind has also been a leader in multiple emergency responses, including COVID-19. During her 15 years of experience, CDR Lind has authored/co-authored 35 publications, presented at national and international conferences, and has been interviewed/featured by numerous media outlets, including the national radio show “Top of Mind with Julie Rose,” USA Today, Consumer Reports, CNN, The Doctors Channel, and HealthDay News. For more information regarding CDC’s Medication Safety Program, the PRevention of Overdoses and Treatment Errors in Children Taskforce (PROTECT) Initiative, and Up & Away, please visit: www.cdc.gov/medicationsafety For the most up-to-date information regarding COVID-19 vaccination, please visit: www.cdc.gov/vaccines/covid-19 To learn more about the United States Public Health Service Commissioned Corps, please visit: www.usphs.gov To learn more about the Epidemic Intelligence Service (EIS) program, please visit: www.cdc.gov/eis Learn more about your ad choices. Visit megaphone.fm/adchoices

I Don’t Lichen It, I Love It! | Holistic Journal Club with Susan Egbert | Holistic Pharmacy Podcast Jul 01, 2022

Show notes

Join host Jenna Carmichael, PharmD for a discussion on Antimycobacterial activity of acetone extract and isolated metabolites from folklore medicinal lichen Usnea laevis Nyl. against drug-sensitive and multidrug-resistant tuberculosis strains with guest Susan Egbert, PharmD. Susan (she/her) completed her PharmD at the University of Louisiana at Monroe (ULM). During school, she realized that there's still not a lot done on natural products despite a fair number of drugs having natural origins. Currently, Susan is a third year PhD candidate in chemistry at the University of Manitoba (U of M). Her research is focusing on lichens, biosynthesis of their secondary metabolites, and their pharmacological activity. Article link: https://pubmed.ncbi.nlm.nih.gov/34536516/ How to get in touch with Susan: Email: sbegbert80@gmail.com Twitter: @lichenlady94 Instagram: @lichenlady94 Dr. Jenna Carmichael of Wobbly Arrow Wellness is a holistic oncology pharmacist and health coach. She works with women on the cancer journey looking for a different perspective on wellness. She combines her knowledge in the oncology space along with holistic healing methods of meditation, reiki, and yoga to help empower her clients to choose the path that works the best for their goals. She also offers genetic testing services to get a true, personalized idea of how her clients process their medications for safe and effective therapy. Go to www.wobblyarrowwellness.com for more information on her services. Learn more about your ad choices. Visit megaphone.fm/adchoices

Navigating the Patient Journey in Specialty Pharmacy- From Evaluation Through Treatment | NASP Jun 30, 2022

Show notes

Podcast Participants: Mike Baldzicki (AscellaHealth), Randy Falkenrath (President, Onco360), Justin Manning, PharmD (Group Vice President, Business Development, Vivid Clear Rx) Summary: The specialty pharmacy patient journey is a process, and it starts at the point of care with patient and prescriber, and it goes all the way through the treatment of therapy. Specialty Pharmacy is defined as the service created to manage the handling and service requirements of specialty pharmaceuticals, including dispensing, distribution, reimbursement, case-management and other services specific to patients with rare and/or chronic diseases. There are a lot of extra steps in dispensing a specialty medication, so there's a lot of work to be done by pharmacists and care coordination teams before the specialty drug is given to the patient. Obviously, there’s a higher cost, and so it takes more personnel and systems, so there is more patient coordination needed prior to the pharmacy to dispense that specialty medication. The value of the specialty pharmacist in helping patients to access treatment, adhere to treatment, and really get the best possible outcome of treatment really cannot be overstressed as specialty pharmacist are often responsible for selecting the most appropriate therapy based on the patient's clinical and financial profile or reviewing that prescribed medication to ensure access for the patient. The Specialty Pharmacy Care Teams provide significant mentoring to patients to ensure not only safety but also effectiveness and being proactive and changing therapy so that patients are really getting the best possible benefit or changing to a different medication that may give them a better effect. The specialty pharmacists are an anchor during therapy that they can rely on to make sure that they are helping them deal with complex, challenging, and sometimes lifelong therapies as the specialty care teams play an important role in the patient care journey. Learn more about your ad choices. Visit megaphone.fm/adchoices

Continuing the Conversation | Optimizing Care for Patients With Endometrial Cancer: A Focus on Pharmacist Interventions and Mitigation of Health Equit... Jun 30, 2022

Show notes

· Recognize the role of biomarker expression in the selection of most appropriate treatment options for patients with endometrial cancer · Review strategies for identification and management of drug-related toxicities in patients receiving therapy with immune checkpoint inhibitors, targeted agents, or combination therapy Faculty: Sarah Hayward, PharmD, BCOP Clinical Pharmacy Specialist, Gynecologic Oncology Stephenson Cancer Center at OU Health University of Oklahoma Health Science Center Oklahoma City, Oklahoma Sarah Hayward, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose: Consultant (advisory board): GSK, Seagen/Genmab Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-22-322-H01-P. The activity is available for CE credit through June 30, 2023. This educational activity is supported by an educational grant from GlaxoSmithKline Learn more about your ad choices. Visit megaphone.fm/adchoices

The Role of JAK Inhibitors in the Management of Atopic Dermatitis Jun 30, 2022

Show notes

This podcast will specifically focus on clinical safety and efficacy data supporting the use of new and emerging JAK inhibitors in the management of AD. Practical counseling points for pharmacists to provide individualized care and proper selection of therapy to patients with AD who are initiating therapy with JAK inhibitors will also be discussed. Faculty experts will review audience questions and identify best practices in the management of AD. o The Role of JAK Inhibitors in the Management of Atopic Dermatitis: Latest Advances and Best Practices for the Pharmacist o Introduction of faculty, affiliations, and disclosures We would like to thank Sarah Lant, PharmD for her contribution in developing the content for this podcast. Lana Gerzenshtein, PharmD and Sarah Lant have no relevant financial relationships with commercial interests to disclose. o Accreditation and support statement PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit. This activity is supported by educational grants from Incyte. Learn more about your ad choices. Visit megaphone.fm/adchoices

Related Podcasts